Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kezar Life Sciences Inc (NQ: KZR )

5.750 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 5.750
Bid (Size) 5.080 (1)
Ask (Size) 7.200 (1)
Prev. Close 5.750
Today's Range 5.750 - 5.750
52wk Range 4.610 - 18.55
Shares Outstanding 60,415,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Kezar Life Sciences, Inc.
Via Business Wire

Performance

YTD
-63.63%
-63.63%
1 Month
-60.51%
-60.51%
3 Month
-59.48%
-59.48%
6 Month
-31.63%
-31.63%
1 Year
+4.93%
+4.93%

More News

Read More
Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%
Via Benzinga
Kezar Life's Lead Asset Fails To Top Placebo In Muscle Inflammation Disease
Via Benzinga
81 Biggest Movers From Yesterday
Via Benzinga
Wells Fargo Analyst Has Questions On Kezar's Lupus Nephritis Data Readout, Stock Plunges
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Dow Rises 100 Points; Lyft Shares Plummet
Via Benzinga
Why Kezar Life Sciences Shares Are Getting Hammered
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Nasdaq Tumbles 100 Points
Via Benzinga
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Kezar Life Sciences, Inc.
Via Business Wire
Insider Weekends: Return Of The Meme Stocks - GameStop (GME) And AMC Entertainment (AMC)
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Here's Why Kezar Life Sciences Shares Are Moving
Via Benzinga
Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
From Kezar Life Sciences, Inc.
Via Business Wire
Kezar Appoints Courtney Wallace to its Board of Directors
From Kezar Life Sciences
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
Stocks Rise Amid Upbeat Consumer Strength Data
Via Talk Markets
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.